Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
Rheumatol Int
    September 2025
  1. ZEKIC T, Blazic F, Katalinic N, Cizmarevic NS, et al
    Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis-a cross-sectional study.
    Rheumatol Int. 2025;45:236.
    >> Share

  2. PATIL H, Prasad S, Subramanian R, Mamadapur M, et al
    Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study.
    Rheumatol Int. 2025;45:235.
    >> Share

  3. DUBEY S, Peddasomayajulu A, Nandagudi A, Maw W, et al
    Enhanced education and support needs in rheumatoid arthritis associated interstitial lung disease (RA-ILD) - patient experiences from a multicentre UK survey.
    Rheumatol Int. 2025;45:237.
    >> Share

  4. NAKAPHAN P, Pajareya P, Jansem P, Phutinart S, et al
    Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2025;45:232.
    >> Share

  5. GULER T, Yurdakul FG, Ataman S, Akgul O, et al
    The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry.
    Rheumatol Int. 2025;45:222.
    >> Share

  6. AKGOZ A, Yakut Y, Tufekci O, Aktas BE, et al
    Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical tiral.
    Rheumatol Int. 2025;45:221.
    >> Share

  7. RYBARCZYK M, Koszela K, Manczak M, Gasik R, et al
    Change in the angle of cervical lordosis after occipito-cervical fixation in the course of instability of C1-C2 in patients with rheumatoid arthritis.
    Rheumatol Int. 2025;45:213.
    >> Share

    August 2025
  8. POTOCKA W, Assy Z, van Tilborg MMA, Bikker FJ, et al
    Association between dry mouth and dry eyes: a systematic literature review of clinical evidence.
    Rheumatol Int. 2025;45:209.
    >> Share

  9. MIROCHA G, Makowska J, Brzezinska O
    Risk factors of nociplastic pain in patients with autoimmune arthritis: web-based cross-sectional survey of patients.
    Rheumatol Int. 2025;45:205.
    >> Share

  10. TORRENTE-SEGARRA V, Huizinga T, Salomon-Escoto K, Da Silva JP, et al
    Biological DMARD survival in rheumatoid arthritis patients in clinical practice: a METEOR registry data analysis.
    Rheumatol Int. 2025;45:190.
    >> Share

  11. NEGRON JB, Lopez-Olivo MA, Carmona L, Christensen R, et al
    The advocacy effect: a grounded theory study on the inclusion of caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritis.
    Rheumatol Int. 2025;45:188.
    >> Share

  12. KARADAG DT, Gokcen N, Yazici A, Cefle A, et al
    Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional national survey of Turkish rheumatologists.
    Rheumatol Int. 2025;45:187.
    >> Share

  13. NOSSENT JC, Keen HI, Preen DB, Inderjeeth CA, et al
    Epidemiology and complications of rheumatoid arthritis in the Indigenous Australian population.
    Rheumatol Int. 2025;45:185.
    >> Share

  14. RUSINOVICH-LOVGACH O, Plaza Z, Fernandez-Castro M, Rosas-Gomez de Salazar J, et al
    High incidence of lymphoma in Sjogren's disease: predictors and mortality implications in a prospective cohort study.
    Rheumatol Int. 2025;45:184.
    >> Share

  15. CHEN G, Mansoor M
    Letter to the editor: social determinants of health in managing late-onset rheumatoid arthritis.
    Rheumatol Int. 2025;45:180.
    >> Share

  16. CALVO-ARANDA E, Novella-Navarro M
    Cardiovascular vasculopathy in gout and rheumatoid arthritis: a shared perspective.
    Rheumatol Int. 2025;45:179.
    >> Share

    July 2025
  17. JAKUBASZEK M, Kwiatkowska B, Plaza M, Maslinska M, et al
    Anti-citrullinated protein antibodies may be prognostic factor for vascularization of the synovial membrane in patients with high activity of RA.
    Rheumatol Int. 2025;45:172.
    >> Share

  18. KOCYIGIT BF, Zimba O, Yessirkepov M, Khojakulova U, et al
    Rheumatoid hand massage therapy to mitigate sarcopenia and improve patients' quality of life: a hypothesis.
    Rheumatol Int. 2025;45:173.
    >> Share

  19. CROMIE DAJ, Stewart SK, Wright GD, Healy EG, et al
    Rheumatoid vasculitis presenting in the absence of rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2025;45:168.
    >> Share

    June 2025
  20. MURPHY L, Murphy G, Cornally N, McHugh S, et al
    Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice.
    Rheumatol Int. 2025;45:158.
    >> Share

  21. FEDORCHENKO Y, Zimba O, Qumar AB, Yessirkepov M, et al
    Physical activity of older patients with rheumatoid arthritis.
    Rheumatol Int. 2025;45:157.
    >> Share

  22. FERNANDEZ-CASTRO M, Plaza-Almuedo Z, Rosas J, Martinez-Taboada V, et al
    Long-term changes in Sjogren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.
    Rheumatol Int. 2025;45:156.
    >> Share

  23. GAVAN SP, Chang S, Rivellese F, Ide Z, et al
    Estimating pain visual analogue scale from health assessment questionnaire for rheumatoid arthritis with beta mixture models.
    Rheumatol Int. 2025;45:154.
    >> Share

  24. ZIMBA O, Baimukhamedov C, Kocyigit BF
    Late-onset rheumatoid arthritis: clinical features, diagnostic challenges, and treatment approaches.
    Rheumatol Int. 2025;45:152.
    >> Share

    May 2025
  25. BRYANT MJ, Lester S, Russell O, Whittle S, et al
    Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients.
    Rheumatol Int. 2025;45:138.
    >> Share

  26. LOPEZ C, Parisi S, Parasiliti-Caprino M, Beccuti G, et al
    Disease activity score is associated with vertebral fragility fractures in patients with rheumatoid arthritis: a cross-sectional multidisciplinary study.
    Rheumatol Int. 2025;45:133.
    >> Share

    April 2025
  27. KONAL O, Bolen F, Guvenc TS, Pehlivan O, et al
    Gout and rheumatoid arthritis are associated with subclinical vascular damage, reduced brachial vasoreactivity and coronary microvascular dysfunction: a case-control study.
    Rheumatol Int. 2025;45:117.
    >> Share

  28. KIRIK A, Sahin N, Baykul M, Bodur H, et al
    Low vaccination rates and awareness status in patients with rheumatoid arthritis: a nationwide cross-sectional survey study.
    Rheumatol Int. 2025;45:116.
    >> Share

  29. BOUR S, Goossens L, Khidir S, de Jong P, et al
    The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis.
    Rheumatol Int. 2025;45:112.
    >> Share

  30. ANYFANTI P, Angeloudi E, Pagkopoulou E, Boutel M, et al
    Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.
    Rheumatol Int. 2025;45:111.
    >> Share

  31. KARPOUZAS GA, Ormseth SR, Van Riel P, Myasoedova E, et al
    Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study.
    Rheumatol Int. 2025;45:106.
    >> Share

  32. ZENGIN ACEMOGLU SS, Bircan AO, Turk I, Coskun Benlidayi I, et al
    Increased fear of falling in primary Sjogren's syndrome: kinesiophobia, impaired balance and poor sleep quality as triggering factors.
    Rheumatol Int. 2025;45:97.
    >> Share

  33. RISSER LM, Witte T, Englbrecht M, Strunz PP, et al
    Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
    Rheumatol Int. 2025;45:100.
    >> Share

  34. KUSZMIERSZ P, Gula Z, Strach M, Nowakowski J, et al
    Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort.
    Rheumatol Int. 2025;45:96.
    >> Share

  35. BENAVENT D, Carmona L, Garcia Llorente JF, Montoro M, et al
    Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review.
    Rheumatol Int. 2025;45:91.
    >> Share

  36. SUZUKI K, Akiyama M, Shimanuki K, Kaneko Y, et al
    Radiological extent predicts prognosis and relapse after acute exacerbation of interstitial lung disease in patients with rheumatoid arthritis: KEIO-RA-cohort.
    Rheumatol Int. 2025;45:92.
    >> Share

  37. FIERRO JJ, Schoots MH, Liefers SC, der Meer BD, et al
    Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases.
    Rheumatol Int. 2025;45:90.
    >> Share

    March 2025
  38. BRZEZINSKA O, Cieplucha A, Slodkowski K, Lewandowska-Polak A, et al
    The incidence of hypersensitivity to non-steroid anti-inflammatory drugs in the group of patients with rheumatoid musculoskeletal disorders: the cross-sectional study.
    Rheumatol Int. 2025;45:82.
    >> Share

  39. KHOJAKULOVA U, Yessirkepov M, Zimba O, Fedorchenko Y, et al
    Massage therapy in rheumatoid arthritis.
    Rheumatol Int. 2025;45:76.
    >> Share

    February 2025
  40. FLOOD M, Ni Gabhann-Dromgoole J, Tynan G, Dillon N, et al
    Use of complementary and alternative medicine (CAM) among people living with Sjogren's: a cross-sectional survey using a modified international CAM questionnaire (I-CAM-Q).
    Rheumatol Int. 2025;45:55.
    >> Share

  41. LINDGREN LH, Hammer NM, Flurey CA, Jensen KV, et al
    Gender differences in illness acceptance and coping strategies among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a cross-sectional survey study.
    Rheumatol Int. 2025;45:52.
    >> Share

  42. FEDORCHENKO Y, Yessirkepov M, Doskaliuk B, Zaiats L, et al
    Thyroid disease as a comorbidity in inflammatory rheumatic diseases.
    Rheumatol Int. 2025;45:46.
    >> Share

  43. BERTHELOT W, Sirois C, Julien AS, Amiable N, et al
    The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.
    Rheumatol Int. 2025;45:44.
    >> Share

  44. PFEUFFER N, Hartmann F, Grahammer M, Simon D, et al
    Early detection of rheumatoid arthritis through patient empowerment by tailored digital monitoring and education: a feasibility study.
    Rheumatol Int. 2025;45:43.
    >> Share

    January 2025
  45. GOKCEN N, Komac A, Tuncer Kuru F, Ozdemir Isik O, et al
    Inadequate sleep hygiene as a key factor in poor sleep quality in systemic sclerosis: an observational, cross-sectional study.
    Rheumatol Int. 2025;45:40.
    >> Share

  46. POLAK D, Korkosz M, Gula Z
    Sleep disorders in rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis.
    Rheumatol Int. 2025;45:36.
    >> Share

  47. JASKOLSKA M, Rytlewska M, Dulak NA, Ulanowski M, et al
    Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.
    Rheumatol Int. 2025;45:35.
    >> Share

  48. PRASANNA H, Inderjeeth CA, Nossent JC, Almutairi KB, et al
    The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2025;45:34.
    >> Share

  49. AUSSERWINKLER M, Gensluckner S, Frey V, Gostner I, et al
    Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study.
    Rheumatol Int. 2025;45:33.
    >> Share

  50. SWEENEY M, Carpenter L, de Souza S, Caton E, et al
    Self-management behaviors do not affect remission but mediate between mental health and disease outcomes in a longitudinal study of rheumatoid arthritis.
    Rheumatol Int. 2025;45:31.
    >> Share

  51. GULA Z, Krzysciak W, Kuszmiersz P, Bystrowska B, et al
    Higher serotonin levels among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis compared to healthy controls assessed by liquid chromatography-tandem mass spectrometry (LC-MS).
    Rheumatol Int. 2025;45:17.
    >> Share

    December 2024
  52. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    Discontinuation of biologic and target-specific therapy in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024;45:6.
    >> Share

  53. WINTER L, Petzinna SM, Skowasch D, Pizarro C, et al
    Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.
    Rheumatol Int. 2024;45:3.
    >> Share

  54. SUZUKI K, Akiyama M, Takei H, Kaneko Y, et al
    Successful rituximab treatment in a seronegative rheumatoid arthritis patient with concurrent cold agglutinin syndrome and immune thrombocytopenia.
    Rheumatol Int. 2024;45:2.
    >> Share

  55. BRIX L, Hedemann-Nielsen A, Medrud L, Fredberg U, et al
    Joint swelling in the hand in rheumatoid arthritis: agreement between clinical evaluation, ultrasonography, magnetic resonance imaging and patient self-evaluation.
    Rheumatol Int. 2024;45:1.
    >> Share

  56. BOURNIA VK, Fragoulis GE, Mitrou P, Tsolakidis A, et al
    Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.
    Rheumatol Int. 2024;44:2837-2846.
    >> Share

  57. XU Z, Han T, Cheng L, Fan J, et al
    The real experience of reporting electronic patient-reported outcomes in patients with inflammatory arthritis and factors influencing participation: a scoping review.
    Rheumatol Int. 2024;44:2795-2806.
    >> Share

  58. ANTON J, Mosquera JM, Calzada J, Iglesias E, et al
    Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.
    Rheumatol Int. 2024;44:2911-2920.
    >> Share

  59. PRASAD CB, Kopp CR, Naidu G, Sharma V, et al
    Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjogren's syndrome: a systematic review of individual patient data.
    Rheumatol Int. 2024;44:2807-2815.
    >> Share

    November 2024
  60. LEE JS, Oh JS, Kim S, Kim YJ, et al
    The association of obesity and the risk of rheumatoid arthritis according to abdominal obesity status: a nationwide population-based study in Korea.
    Rheumatol Int. 2024 Nov 22. doi: 10.1007/s00296-024-05748.
    >> Share

  61. GULA Z, Losinska K, Kuszmiersz P, Strach M, et al
    A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.
    Rheumatol Int. 2024 Nov 11. doi: 10.1007/s00296-024-05740.
    >> Share

  62. DEY M, Doskaliuk B, Parodis I, Lindblom J, et al
    COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
    Rheumatol Int. 2024 Nov 6. doi: 10.1007/s00296-024-05742.
    >> Share

    October 2024
  63. UHRENHOLT L, Sorensen MER, Lauridsen KB, Duch K, et al
    Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
    Rheumatol Int. 2024;44:1897-1908.
    >> Share

  64. HINKEMA HJ, Westra J, Arends S, Brouwer E, et al
    Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study.
    Rheumatol Int. 2024;44:2007-2016.
    >> Share

  65. NIELLY H, Biale L, Gilardin L, Carmoi T, et al
    Tocilizumab-induced psoriatic eruption : a case report and a case-based review.
    Rheumatol Int. 2024;44:2205-2212.
    >> Share

    September 2024
  66. XIE W, Huang H, Geng Y, Fan Y, et al
    Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China.
    Rheumatol Int. 2024 Sep 12. doi: 10.1007/s00296-024-05713.
    >> Share

  67. KOSCINSKA-SHUKLA I, Jaskolska M, Chylinska M, Jaskolski D, et al
    Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sjogren syndrome - a prospective observational study on 50 patients.
    Rheumatol Int. 2024;44:1739-1747.
    >> Share

  68. DE OLIVEIRA JL, Cordeiro RA, Guedes LKN, Pasoto SG, et al
    Shrinking lung syndrome in primary Sjogren's syndrome: a case-based review.
    Rheumatol Int. 2024;44:1795-1800.
    >> Share

    August 2024
  69. TERMINE M, Davidson Z, Choi T, Leech M, et al
    What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping review.
    Rheumatol Int. 2024 Aug 27. doi: 10.1007/s00296-024-05691.
    >> Share

  70. SCHAFER VS, Winter L, Skowasch D, Bauer CJ, et al
    Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study.
    Rheumatol Int. 2024 Aug 21. doi: 10.1007/s00296-024-05685.
    >> Share

  71. SAGTAGANOV Z, Bekaryssova D
    Complex rehabilitation of patients with rheumatoid arthritis.
    Rheumatol Int. 2024 Aug 3. doi: 10.1007/s00296-024-05669.
    >> Share

    July 2024
  72. HERMANN S, Palmowski A, Hermann KGA, Muche B, et al
    Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2024 Jul 29. doi: 10.1007/s00296-024-05655.
    >> Share

  73. MAHAJAN A, Mruthyunjaya P, Padhee S, Ahmed S, et al
    People with osteoarthritis have a higher component of neuropathic pain as compared to those with rheumatoid arthritis: A cross-sectional study.
    Rheumatol Int. 2024 Jul 12. doi: 10.1007/s00296-024-05657.
    >> Share

  74. SALEEM RA, Ramadan M, Elshaaer Y, Sukkarieh H, et al
    Laboratory features and pharmacological management of early and late-onset primary Sjogren's syndrome.
    Rheumatol Int. 2024;44:1317-1325.
    >> Share

  75. ARYA PVA, Marnet E, Rondla M, Tan JW, et al
    Renal manifestations in adult-onset Still's disease: a systematic review.
    Rheumatol Int. 2024;44:1209-1218.
    >> Share

  76. POPOVA V, Geneva-Popova M, Popova-Belova S, Doykov M, et al
    Diagnostic and prognostic role of serum interleukin-6 and carotid ultrasonography to detect subclinical atherosclerosis in patients with RA and ANCA-associated vasculitis.
    Rheumatol Int. 2024;44:1295-1303.
    >> Share

  77. BOTABEKOVA A, Baimukhamedov C, Zimba O, Mehta P, et al
    Examining the clinical and radiological landscape of rhupus: navigating the challenges in disease classification.
    Rheumatol Int. 2024;44:1185-1196.
    >> Share

  78. FEDORCHENKO Y, Zimba O, Yatsyshyn R, Doskaliuk B, et al
    The interplay between rheumatic diseases and pulmonary health.
    Rheumatol Int. 2024;44:1179-1184.
    >> Share

  79. PASOTO SG, Villamarin LEB, de Vinci Kanda Kupa L, Deveza GBH, et al
    Assessment of hydroxychloroquine blood levels in Sjogren's disease patients: drug adherence and clinical associations.
    Rheumatol Int. 2024;44:1305-1315.
    >> Share

    June 2024
  80. SERNA-PENA G, Flores-Gutierrez DP, Vega-Sevilla LF, Villarreal-Saenz MA, et al
    Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional survey.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05648.
    >> Share

  81. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D, Suigenbayev D, et al
    Managing rheumatoid arthritis and cardiovascular disease: the role of physical medicine and rehabilitation.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05651.
    >> Share

  82. BAKKER NF, van Weely SFE, Boonen A, Vliet Vlieland TPM, et al
    Work-related support for employed and self-employed people with rheumatoid arthritis or axial spondyloarthritis: a cross-sectional online survey of patients.
    Rheumatol Int. 2024 Jun 20. doi: 10.1007/s00296-024-05643.
    >> Share

  83. RAMOS-PETERSEN L, Reinoso-Cobo A, Ortega-Avila AB, Garcia-Campos J, et al
    A clinical practice guideline for the management of the foot and ankle in rheumatoid arthritis.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05633.
    >> Share

  84. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D
    Yoga as a complementary therapy for rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05641.
    >> Share

  85. CONTRERAS DG, McLane P, Barber CEH, Lin K, et al
    Emergency department utilization by persons with rheumatoid arthritis: a population-based cohort study.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05627.
    >> Share

  86. PETZINNA SM, Winter L, Skowasch D, Pizarro C, et al
    Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study.
    Rheumatol Int. 2024;44:1025-1034.
    >> Share

    May 2024
  87. SWEENEY M, Adas MA, Cope A, Norton S, et al
    Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review.
    Rheumatol Int. 2024 May 22. doi: 10.1007/s00296-024-05574.
    >> Share

    April 2024
  88. KRAJEWSKA-WLODARCZYK M, Szelag M, Batko B, Zuber Z, et al
    Rheumatoid arthritis epidemiology: a nationwide study in Poland.
    Rheumatol Int. 2024 Apr 27. doi: 10.1007/s00296-024-05591.
    >> Share

  89. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
    Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
    Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
    >> Share

  90. LINDGREN LH, de Thurah A, Thomsen T, Hetland ML, et al
    Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
    Rheumatol Int. 2024 Apr 2. doi: 10.1007/s00296-024-05553.
    >> Share

  91. FEDORCHENKO Y, Mahmudov K, Abenov Z, Zimba O, et al
    Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs.
    Rheumatol Int. 2024;44:583-591.
    >> Share

  92. ASMAR S, Messaykeh J, Hilal N, Rida MA, et al
    Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
    Rheumatol Int. 2024;44:725-736.
    >> Share

    March 2024
  93. GRANT WB
    The present understanding of the effects of dietary red meat and the Mediterranean diet on rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 27. doi: 10.1007/s00296-024-05587.
    >> Share

  94. KALETA K, Krupa J, Suchy W, Sopel A, et al
    Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 24. doi: 10.1007/s00296-024-05556.
    >> Share

  95. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
    Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
    Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
    >> Share

  96. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
    Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
    Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
    >> Share

  97. LARKIN L, McKenna S, Pyne T, Comerford P, et al
    Promoting physical activity in rheumatoid arthritis through a physiotherapist led behaviour change-based intervention (PIPPRA): a feasibility randomised trial.
    Rheumatol Int. 2024 Mar 4. doi: 10.1007/s00296-024-05544.
    >> Share

  98. DURUOZ MT, Nas K, Kasman SA, Oz N, et al
    Validity and reliability of the Duruoz Hand Index in patients with psoriatic arthritis.
    Rheumatol Int. 2024;44:535-542.
    >> Share

  99. COSKUN BN, Yagiz B, Ocakoglu G, Dalkilic E, et al
    Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.
    Rheumatol Int. 2024;44:509-515.
    >> Share

  100. COX N, Hawarden A, Bajpai R, Farooq S, et al
    The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.
    Rheumatol Int. 2024;44:435-440.
    >> Share

  101. KAMINSKI M, Hrycaj P
    Celebrities influence on rheumatic diseases interest: a Google Trends analysis.
    Rheumatol Int. 2024;44:517-521.
    >> Share

    February 2024
  102. SHARMA P, Brown S, Sokoya EM
    Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
    Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
    >> Share

    January 2024
  103. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
    Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
    >> Share

  104. COUREL-IBANEZ J, Vetrovsky T, Ruzickova N, Maranon C, et al
    Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
    Rheumatol Int. 2024 Jan 5. doi: 10.1007/s00296-023-05507.
    >> Share

  105. MORALIYSKA R, Georgiev T, Bogdanova-Petrova S, Shivacheva T, et al
    Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
    Rheumatol Int. 2024;44:165-172.
    >> Share

    December 2023
  106. DURUOZ MT, Ataman S, Bodur H, Cay HF, et al
    Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Rheumatol Int. 2023 Dec 29. doi: 10.1007/s00296-023-05515.
    >> Share

  107. DUBEY S, Woodhead F
    Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
    Rheumatol Int. 2023 Dec 12. doi: 10.1007/s00296-023-05505.
    >> Share

    November 2023
  108. TEUWEN MMH, Vlieland TPMV, van Weely SFE, Schoones JW, et al
    Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.
    Rheumatol Int. 2023 Nov 30. doi: 10.1007/s00296-023-05502.
    >> Share

  109. TEUWEN MMH, van Weely SFE, Vliet Vlieland TPM, Douw T, et al
    Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.
    Rheumatol Int. 2023 Nov 25. doi: 10.1007/s00296-023-05487.
    >> Share

  110. MIHAYLOVA V, Kazakova M, Batalov Z, Karalilova R, et al
    JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2023 Nov 20. doi: 10.1007/s00296-023-05501.
    >> Share

  111. DE FIGUEIREDO LQ, de Andrade Lopes FO, Franco AS, Giardini HAM, et al
    Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2023 Nov 4. doi: 10.1007/s00296-023-05494.
    >> Share

  112. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
    Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
    Rheumatol Int. 2023;43:2057-2064.
    >> Share

  113. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
    The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
    Rheumatol Int. 2023;43:2031-2036.
    >> Share

    October 2023
  114. COSKUN BENLIDAYI I
    Exercise therapy for improving cardiovascular health in rheumatoid arthritis.
    Rheumatol Int. 2023 Oct 31. doi: 10.1007/s00296-023-05492.
    >> Share

  115. KOUNATIDIS DC, Papadimitropoulos V, Avramidis K, Plenga E, et al
    Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review.
    Rheumatol Int. 2023 Oct 18. doi: 10.1007/s00296-023-05483.
    >> Share

  116. FLOURI I, Goutakoli P, Repa A, Bertsias A, et al
    Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
    Rheumatol Int. 2023 Oct 10. doi: 10.1007/s00296-023-05455.
    >> Share

  117. THOMSEN T, Aadahl M, Hetland ML, Esbensen BA, et al
    Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
    Rheumatol Int. 2023 Oct 3. doi: 10.1007/s00296-023-05466.
    >> Share

    September 2023
  118. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05458.
    >> Share

  119. SULLI A, Clini P, Bruzzone G, Signori A, et al
    An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
    Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
    >> Share

  120. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
    Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016